Kingdom Capital

AstrumU, Inc. is a technology-driven company that focuses on connecting employers with recent graduates through its innovative platform. Founded in 2017 and headquartered in Kirkland, Washington, with an additional office in Kansas City, Kansas, AstrumU enables educational institutions and lifelong learners to assess the return on educational investments. The AstrumU platform employs artificial intelligence to analyze and synthesize data from students, schools, and employers, providing predictive insights that enhance recruitment and talent development. By quantifying skills based on verifiable data, the platform not only drives enrollment and enhances industry engagement but also aims to increase economic mobility for individuals entering the workforce.

IntEngine, operating under the name Tanjing Technology, specializes in the development of storage-first architecture, focusing on end-side AI chips and solutions for Internet of Things (IoT) terminal devices. The company is dedicated to enhancing efficiency in daily life through innovative software algorithms and chip hardware technology. IntEngine emphasizes deep learning and machine learning algorithms, providing tailored neural networks and terminal equipment to assist in security upgrades for monitoring systems. By delivering advanced digitalization solutions, IntEngine aims to serve industrial users effectively, facilitating improvements in operational efficiency and security.

Canopy Biosciences, founded in 2016 and headquartered in St. Louis, Missouri, is a biotechnology company specializing in research tools for genetic engineering, molecular biology, and personalized medicine. The company offers a comprehensive range of products and services designed to facilitate gene editing, gene expression analysis, and bioprocessing. One of its key technologies, TUNR, targets translation elongation by inserting polyA tracks into specific coding regions of the genome, effectively reducing mRNA levels and suppressing protein expression. This innovative approach supports biomedical researchers at universities, research institutions, and within the biotechnology and pharmaceutical sectors, accelerating scientific discovery and enhancing the field of genetic engineering. Canopy Biosciences operates as a subsidiary of Bruker Corporation.